Clinical Trial: CBP-0276 to Reduce Opioid Use in Adults Undergoing Major Orthopedic Surgery

U.S., July 8 -- ClinicalTrials.gov registry received information related to the study (NCT07687966) titled 'CBP-0276 to Reduce Opioid Use in Adults Undergoing Major Orthopedic Surgery' on June 25.

Brief Summary: Randomized, double-blind, clinical study to evaluate the safety and efficacy of CBP-0276 at doses of 600 mg/day in reducing opioid use in pain management in adult patients undergoing major orthopedic surgery. Subjects will be allocated in 2 groups. One group will receive oxycodone (standard of care) + CBP-0276 at a dose of 600 mg, orally once daily for 28 days. A second group will receive oxycodone (standard of care) + placebo for CBP-0276, orally once daily for 28 days

Study Start Date: May 08

Study Type: INTERVENTIONAL

Conditi...